(2026). Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma. ImmunoTargets and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Integrin Alpha8beta1 Is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma."
ImmunoTargets and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Integrin Alpha8beta1 Is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma."
ImmunoTargets and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.